Focused Issue on Opioid Utility the Other Half of Equianalgesia

Posted On 2019-08-30 06:46:31


This focused issue on “Opioid Utility the Other Half of Equianalgesia” is edited by Dr. Mellar P. Davis, Palliative Services, Geisinger Health System, Danville, PA, USA.

Dr. Mellar P. Davis, is a member of the Palliative Care Department, and Section Head, Geisinger Medical System Danville, PA. He has been a member of the Geisinger Medical Staff since August 2016. In his role as Section Head, Dr. Davis is responsible for developing palliative care services throughout the Geisinger Medical System including outpatient and inpatient services. In addition, Dr. Davis works with the Geisinger Hospice Services to develop and coordinate care within the central region.

Dr. Davis was a member of the Cleveland Clinic Palliative Care section, Taussig Cancer Institute and fellowship director until joining the Geisinger Medical System. He was the co- chair of the Palliative Care Study Group of the Multinational Association of Supportive Care (MASCC) and a past board member since 2010 and was recently re-elected to the board for 2018-2020. He is a Professor of Medicine in The Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, since 2009 and elected as a Fellow to the American Academy of Hospice and Palliative Medicine in 2010. He was Editor in Chief of Progress on Palliative Care from 2008-2018 and is currently subeditor of Current Treatment Options in Cancer. His present duties within the Editor-in-Chief of PC FACS (Fast Article Critical Summary for Clinicians in Palliative Care).

Focused issue outline:

  1. Preface to This Focused Issue
  2. Opioid Utility. What is it and Why is it Important?
  3. Beyond Equianalgesia. Why Equal Analgesic Tables are not the Answer to Opioid Dosing?
  4. Practical Analgesic Utility
  5. Opioids and Sedatives: Narrowing Utility of Both
  6. Do Biased Mu Agonist Increase Opioid Utility?
  7. What is the Evidence that Targeting Multiple Opioid Receptors Will Improve Opioid Utility?
  8. Patient Populations Which Influence Opioid Utility
  9. Respiratory Function and Opioid Safety/Utility
  10. Does Opioid Utility Have a Place in Clinical Discussions About Opioid
  11. Does Oxycodone Have Greater Utility Than Other Opioids?
  12. Utility and Safety: Sufentanil versus Fentanyl
  13. Opioid Utility in COPD: A Balancing Act
  14. Levorphanol Versus Methadone: Safety Considerations